Skip to content
SIIS — Servicio de Información e Investigación Social. Fundación Eguía-Careaga Fundazioa
Está en:
  • Inicio>
  • Centro de documentación>
  • Catálogo bibliográfico
Hemen zaude:
  • Hasiera>
  • Dokumentazio zentroa>
  • Katalogo bibliografikoa
You are here:
  • Home>
  • Documentation centre>
  • Library catalogue
VuFind
  • Login
    • Bootstrap
    • Siis
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
    • Māori
Advanced
  • RATIONALE OF PSYCHOTROPIC MEDI...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE

Saved in:
CHATURVEDI, S.K., ET AL., RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE. PROGRESS IN PALLIATIVE CARE, Vol. 4, no. 3 (1996), p. 80-84.
Ref. 55108
Location: SIIS R.1147
Solicitar documento
Palabras clave:
Cáncer, Enfermos terminales, Fármacos, Psicótropos, Síntomas, Tratamiento
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Similar Items

  • PSYCHOTROPIC MEDICATION HISTORY OF INPATIENT ADOLESCENTS. IS THERE A RATIONALE FOR BENZODIAZEPINE PRESCRIPTION?
    by: ILOMAKI, R.
  • PSYCHOTROPIC MEDICATION FOR ADHD
    by: SAFER, D.J
  • GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
    by: EINFELD, S.L
  • AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
    by: MAHAN, S.
  • A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS
    by: SCHALL, C.

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs